Quarterly Results

LINK PHARMA CHEM LTD.

NSE : NABSE : 524748ISIN CODE : INE302F01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE44.110.01 (+0.02 %)
PREV CLOSE ( ) 44.10
OPEN PRICE ( ) 44.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3214
TODAY'S LOW / HIGH ( )43.21 44.62
52 WK LOW / HIGH ( ) 34.1168.77
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
79.39
60.5
78.76
92.91
Total Expenditure
76.6
69.36
88.39
90.1
PBIDT (Excl OI)
2.79
-8.86
-9.63
2.81
Other Income
3.7
-0.26
3.07
-0.25
Operating Profit
6.49
-9.12
-6.55
2.55
Interest
2.31
2.18
2.29
2.6
Exceptional Items
NA
NA
NA
NA
PBDT
4.18
-11.3
-8.84
-0.04
Depreciation
2.66
2.61
2.58
2.3
Profit Before Tax
1.52
-13.91
-11.43
-2.34
Tax
-0.69
-3.7
-3.19
-0.41
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2.21
-10.21
-8.23
-1.93
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
2.21
-10.21
-8.23
-1.93
Equity Capital
44.41
44.41
44.41
44.41
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
0.49
-2.29
-1.85
-0.43
Calculated EPS (Annualised)
1.99
-9.19
-7.42
-1.73
No of Public Share Holdings
2154143
2154143
2154143
2154143
% of Public Share Holdings
48.51
48.51
48.51
48.51
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
3.51
-14.64
-12.22
3.02
PBIDTM%
8.17
-15.07
-8.32
2.75
PBDTM%
5.26
-18.67
-11.23
-0.04
PBTM%
1.91
-22.99
-14.51
-2.51
PATM%
2.78
-16.87
-10.46
-2.07
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.